MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0042883
Khandelwal Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹240.41 Cr
▲ 2% YoY
Net profit · FY 2025
₹6 Cr
Net margin 2.5%
EBITDA · FY 2025
₹11.91 Cr
EBITDA margin 5%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹45.5 Cr
Satisfied ₹18 Cr
Company age
81 yrs
Est. 1945
Employees · EPFO
810
Provident fund records
About Khandelwal Laboratories Private Limited
Data last updated:
Khandelwal Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 September 1945 and has been in existence for over 81 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH1945PTC004554. Its GSTIN is 27AAACK4225E1ZX (Maharashtra). The company holds 6 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Khandelwal Laboratories Limited. It is led by directors including Anuradha Sanjeev Khandelwal and Subhash Kashinath Pai Kakode.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 79/87 D.Lad Path Kala Chowkie, Mumbai, Maharashtra, India – 400033.
As per the financials filed for FY 2025, the company reported a revenue of ₹240.41 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹6 Cr (net margin 2.5%) and EBITDA of ₹11.91 Cr (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 1% over five years.
The company has about 810 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Khandelwal Laboratories. As per MCA filings, the company has open charges of ₹45.5 Cr and satisfied charges of ₹18 Cr on record. Court records list 119 cases involving the company, including 63 filed by the company and 56 filed against it; 15 cases are pending. The company has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2 Cr; the latest was in March 2023. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Aet Laboratories Private Limited with revenue of ₹246.84 Cr. The company has 16 MSME Form 1 returns on record between 2019 and 2023, listing 1,463 overdue payments to 58 micro and small suppliers.
Khandelwal Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0042883). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website khandelwallab.com.
Company details
CIN U74999MH1945PTC004554
Registration Number 004554
Incorporation Date 27 September 1945
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0042883
Key People
Anuradha Sanjeev Khandelwal Director Subhash Kashinath Pai Kakode Director Sanjeev Khandelwal Director Recognitions & Rankings of Khandelwal Laboratories
Contact details
Khandelwal Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is khandelwallab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address79/87 D.Lad Path Kala Chowkie, Mumbai, Maharashtra, India – 400033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Khandelwal Laboratories Private Limited, buy the company report.
Comprehensive company report
Khandelwal Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Khandelwal Laboratories operates one associated brand: Khandelwal Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| APIs and formulations are manufactured, focusing on oncology treatments. | khandelwallab.com |
Business activity
The main business activity of Khandelwal Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Khandelwal Laboratories Private Limited, buy the company report.
Financials of Khandelwal Laboratories Private Limited
FY 2024 filings availableKhandelwal Laboratories Private Limited reported revenue of ₹240.41 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹240.41 Cr ▲ 2%
Net profit · FY 2025
₹6 Cr margin 2.5%
EBITDA · FY 2025
₹11.91 Cr margin 5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 7%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 8%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 2% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.91 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Khandelwal Laboratories Private Limited, buy the company report.
Board of directors of Khandelwal Laboratories Private Limited
Khandelwal Laboratories has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuradha Sanjeev Khandelwal | Director | 01 Oct 2016 | 10 Years 1 Months | Current |
| Subhash Kashinath Pai Kakode | Director | 01 Mar 2011 | 15 Years 8 Months | Current |
| Sanjeev Khandelwal | Director | 20 Aug 1993 | 33 Years 2 Months | Current |
| Sunita Khandelwal | Director | 01 Oct 2016 | 10 Years 1 Months | Current |
| Vijay Kumar Goel Also directs: Shudh Edible Products Private Limited, Sonitron Limited, Intellecta Infotech Private Limited and 1 more | Director | 18 Jun 1993 | 33 Years 4 Months | Current |
Peer comparison
Khandelwal Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aet Laboratories Private Limited | ₹246.84 Cr (FY 2025) | 15.0% | Sangareddy, Telangana, India | |||
| Icpa Health Products Ltd | ₹246.81 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Vivek Pharmachem (India) Limited | ₹245.53 Cr (FY 2025) | -8.0% | Jaipur, Rajasthan, India | |||
| Blue Circle Organics Private Limited | ₹243.24 Cr (FY 2019) | 35.0% | Mumbai, Maharashtra, India | |||
| Khandelwal Laboratories Private Limitedthis company | ₹240.41 Cr (FY 2025) | ₹6 Cr | 2.5% | 2.0% | 810 | Mumbai, Maharashtra, India |
| Ideal Cures Private Limited | ₹239.81 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Healthcaps India Limited | ₹239.43 Cr (FY 2025) | -2.0% | Fatehpur, Punjab, India | |||
| Kemwell Biopharma Private Limited | ₹239.14 Cr (FY 2025) | 10.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Khandelwal Laboratories Private Limited, buy the company report.
Auditor
Khandelwal Laboratories Private Limited is audited by Warde & Shah Chartered Accountants for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Warde & Shah Chartered Accountants | FY 2024 | 121166W |
Shareholding
The shareholding of Khandelwal Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Khandelwal Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹45.5 Cr
Satisfied charges
₹18 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2024 | 101061977 | Others | ₹20 Cr | Open | |
| 30 Jan 2015 | 10556938 | Axis Bank Limited | ₹5 Cr | Open | |
| 12 Apr 2005 | 90238531 | Others | ₹10.5 Cr | Open | |
| 28 Jun 2004 | 90241156 | Others | ₹10 Cr | Open | |
| 19 Apr 2011 | 10288990 | Punjab National Bank | ₹1 Cr | Satisfied |
To see the full charge records of Khandelwal Laboratories Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Khandelwal Laboratories Private Limited has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2 Cr; the latest was in March 2023.
Total deals
4
Secondary share transfers
2
Funding round
1
Acquisition
1
Disclosed funding
₹2 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: an individual |
| Apr 2008 | Acquisition | ₹115.96 Cr | Buyer: Piramal Enterprises Ltd Seller: Khandelwal Laboratories Private Limited |
| Mar 2007 | Funding round | ₹2 Cr | Investors: an individual |
| Feb 2007 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Khandelwal Laboratories Private Limited has 119 court cases on record: 63 filed by Khandelwal Laboratories, 56 filed against it. 15 cases are pending and 104 are disposed.
Total cases
119
Filed by the company
63
Filed against the company
56
Pending
15
Disposed
104
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 78 | 37 | 10 |
| District courts | 35 | 14 | 5 |
| Supreme Court | 6 | 5 | 0 |
Cases on record (5 of 119)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (EX.P.) | Filed by the company against Nava Healthcare P. Ltd. Through Its Director Rakesh Bhikhalal Shah | Pending |
| Bombay High Court | Court case (NMCD) | Filed against the company by Ajanta Pharma Limited | Pending |
| Bombay High Court | Court case (NMA) | Filed against the company by M/S Elder Health Care Ltd | Pending |
| High Court | Arbitration matter | Filed by the company against Gala Realtors Private Limited | Disposed |
| High Court of Delhi | Court case (CONT.CAS(C)) | Filed by the company against Nava Healthcare Pvt. Ltd. & Ors. | Disposed |
To see the full case history of Khandelwal Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Khandelwal Laboratories Private Limited was last rated by Care on 06 Sep 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 06 Sep 2022 |
To see the full credit ratings and regulatory alerts of Khandelwal Laboratories Private Limited, buy the company report.
MSME payment delays
Khandelwal Laboratories Private Limited has 16 MSME Form 1 returns on record between 2019 and 2023, listing 1,463 overdue payments to 58 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 58)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Care Hygiene Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Khandelwal Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Khandelwal Laboratories has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Khandelwal Laboratories Private Limited has a workforce of 810 employees on its EPFO records as of Mar 18, 2025, across 1 active EPFO establishment.
Employee count
810
Active EPFO establishments
1
Employee growth
3.58%
GST
Khandelwal Laboratories has 6 GST registrations: 5 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
6
Active
5
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACK4225E1ZX | Maharashtra | Active | 01 Jul 2017 |
| 05AAACK4225E1Z3 | Uttarakhand | Active | 01 Jul 2017 |
| 09AAACK4225E1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
| 24AAACK4225E1Z3 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Khandelwal Laboratories Private Limited, buy the company report.
Recent activity
Khandelwal Laboratories Private Limited has 10 board changes on record since 1993: 5 appointments and 5 cessations. The latest: Anuradha Sanjeev Khandelwal ceased to be Additional Director on 29 Sep 2017.
Charges
A charge registered on 19 Apr 2011 via Charge ID 10288990 with Punjab National Bank was fully satisfied on 16 May 2025.
Charges
A charge registered on 23 Feb 2011 via Charge ID 10273826 with Punjab National Bank was fully satisfied on 16 May 2025.
Charges
A charge registered on 30 Nov 2007 via Charge ID 10080241 with Others was fully satisfied on 16 May 2025.
Charges
A charge registered on 16 May 2007 via Charge ID 10055633 with Punjab National Bank was fully satisfied on 16 May 2025.
Charges
A charge registered on 12 Sep 2006 via Charge ID 10020537 with Punjab National Bank was fully satisfied on 16 May 2025.
Charges
A charge with Others of Rs. 20.00 Cr registered on 31 Dec 2024 with Charge ID 101061977 was modified on 06 May 2025.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101061977 was registered on 31 Dec 2024.
AGM
Khandelwal Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Khandelwal Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others of Rs. 11.00 Cr registered on 30 Nov 2007 with Charge ID 10080241 was modified on 16 Sep 2023.
Charges
A charge with Others of Rs. 10.50 Cr registered on 12 Apr 2005 with Charge ID 90238531 was modified on 16 Sep 2023.
Charges
A charge with Others of Rs. 10.00 Cr registered on 28 Jun 2004 with Charge ID 90241156 was modified on 16 Sep 2023.
19 earlier events are in the company report.
Frequently asked questions
Khandelwal Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 September 1945 (81+ years old) and is registered under CIN U74999MH1945PTC004554.
Khandelwal Laboratories has 5 current directors:
- Anuradha Sanjeev Khandelwal - Director
- Subhash Kashinath Pai Kakode - Director
- Sanjeev Khandelwal - Director
- Sunita Khandelwal - Director
- Vijay Kumar Goel - Director
The latest financial statements of Khandelwal Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Khandelwal Laboratories is 27AAACK4225E1ZX, registered in Maharashtra. The company has 6 GST registrations in all, of which 5 are active and 1 is cancelled or inactive. Other active GSTINs include 05AAACK4225E1Z3 (Uttarakhand), 09AAACK4225E1ZV (Uttar Pradesh), 24AAACK4225E1Z3 (Gujarat).
The CIN (Corporate Identification Number) of Khandelwal Laboratories is U74999MH1945PTC004554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Khandelwal Laboratories has 119 court cases on record: 63 filed by the company and 56 filed against it. 15 are pending. Most are in the high courts.
Khandelwal Laboratories was incorporated on 27 September 1945, making it 81+ years old. It is registered with the Registrar of Companies, Mumbai.
Khandelwal Laboratories has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2 Cr; the latest was in March 2023.
The peers of Khandelwal Laboratories by revenue are Aet Laboratories Private Limited, Icpa Health Products Ltd, Vivek Pharmachem (India) Limited, Blue Circle Organics Private Limited, Ideal Cures Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anuradha Sanjeev Khandelwal ceased to be Additional Director on 29 Sep 2017. Sunita Khandelwal ceased to be Additional Director on 29 Sep 2017. Anuradha Sanjeev Khandelwal was appointed as Director on 01 Oct 2016. Khandelwal Laboratories has 10 board changes on record in total.
Yes, Khandelwal Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0042883).
Khandelwal Laboratories has 16 MSME Form 1 returns on record between 2019 and 2023, listing 1,463 overdue payments to 58 micro and small suppliers. The latest return was filed on 08 Nov 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages